{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:19:26Z","timestamp":1787804366340,"version":"build-2784847793"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02229-w","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:13:16Z","timestamp":1782144796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ITM2A promotes thyroid cancer differentiation through metabolic reprogramming and enhances PD-L1-dependent T-cell responses"],"prefix":"10.1007","volume":"26","author":[{"given":"Wuhui","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2229_CR1","doi-asserted-by":"publisher","unstructured":"Forma A, Klodnicka K, Pajak W, Flieger J, Teresinska B, Januszewski J, et al. Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies. Int J Mol Sci. 2025;26(11). https:\/\/doi.org\/10.3390\/ijms26115173.","DOI":"10.3390\/ijms26115173"},{"key":"2229_CR2","doi-asserted-by":"publisher","unstructured":"Han PZ, Ye WD, Yu PC, Tan LC, Shi X, Chen XF, et al. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer. JCI Insight. 2024;9(8). https:\/\/doi.org\/10.1172\/jci.insight.173712.","DOI":"10.1172\/jci.insight.173712"},{"issue":"4","key":"2229_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","volume":"9","author":"A Miranda-Filho","year":"2021","unstructured":"Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225\u201334. https:\/\/doi.org\/10.1016\/S2213-8587(21)00027-9.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"32","key":"2229_CR4","doi-asserted-by":"publisher","first-page":"e2401712","DOI":"10.1002\/advs.202401712","volume":"11","author":"W Zhang","year":"2024","unstructured":"Zhang W, Ruan X, Huang Y, Zhang W, Xu G, Zhao J, et al. SETMAR Facilitates the Differentiation of Thyroid Cancer by Regulating SMARCA2-Mediated Chromatin Remodeling. Adv Sci (Weinh). 2024;11(32):e2401712. https:\/\/doi.org\/10.1002\/advs.202401712.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2229_CR5","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1038\/s41467-025-58910-3","volume":"16","author":"Z Pan","year":"2025","unstructured":"Pan Z, Tan Z, Xu N, Yao Z, Zheng C, Shang J, et al. Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancers. Nat Commun. 2025;16(1):3601. https:\/\/doi.org\/10.1038\/s41467-025-58910-3.","journal-title":"Nat Commun"},{"issue":"7","key":"2229_CR6","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.3390\/curroncol31070286","volume":"31","author":"F Volpe","year":"2024","unstructured":"Volpe F, Nappi C, Zampella E, Di Donna E, Maurea S, Cuocolo A, et al. Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer. Curr Oncol. 2024;31(7):3870\u201384. https:\/\/doi.org\/10.3390\/curroncol31070286.","journal-title":"Curr Oncol"},{"issue":"13","key":"2229_CR7","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.7150\/thno.57689","volume":"11","author":"JM Oh","year":"2021","unstructured":"Oh JM, Ahn BC. Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS. Theranostics. 2021;11(13):6251\u201377. https:\/\/doi.org\/10.7150\/thno.57689.","journal-title":"Theranostics"},{"issue":"1","key":"2229_CR8","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.1038\/s41467-024-48173-9","volume":"15","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Wu Y, Fu J, Yu X, Su Y, Jia S, et al. Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF\/MAPK-mediated tumorigenesis. Nat Commun. 2024;15(1):4108. https:\/\/doi.org\/10.1038\/s41467-024-48173-9.","journal-title":"Nat Commun"},{"key":"2229_CR9","doi-asserted-by":"publisher","first-page":"1346476","DOI":"10.3389\/fendo.2024.1346476","volume":"15","author":"P Chen","year":"2024","unstructured":"Chen P, Yao Y, Tan H, Li J. Systemic treatments for radioiodine-refractory thyroid cancers. Front Endocrinol (Lausanne). 2024;15:1346476. https:\/\/doi.org\/10.3389\/fendo.2024.1346476.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2229_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/cco.0000000000000797","volume":"34","author":"RS Scheffel","year":"2022","unstructured":"Scheffel RS, Dora JM, Maia AL. BRAF mutations in thyroid cancer. Curr Opin Oncol. 2022;34(1):9\u201318. https:\/\/doi.org\/10.1097\/cco.0000000000000797.","journal-title":"Curr Opin Oncol"},{"issue":"35","key":"2229_CR11","doi-asserted-by":"publisher","first-page":"eadg7125","DOI":"10.1126\/sciadv.adg7125","volume":"9","author":"P Yu","year":"2023","unstructured":"Yu P, Qu N, Zhu R, Hu J, Han P, Wu J, et al. TERT accelerates BRAF mutant\u2013induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis. Sci Adv. 2023;9(35):eadg7125. https:\/\/doi.org\/10.1126\/sciadv.adg7125.","journal-title":"Sci Adv"},{"issue":"5","key":"2229_CR12","doi-asserted-by":"publisher","first-page":"e1694","DOI":"10.1002\/ctm2.1694","volume":"14","author":"P Zhang","year":"2024","unstructured":"Zhang P, Guan L, Sun W, Zhang Y, Du Y, Yuan S, et al. Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAFV600E-associated thyroid carcinoma. Clin Translational Med. 2024;14(5):e1694. https:\/\/doi.org\/10.1002\/ctm2.1694.","journal-title":"Clin Translational Med"},{"key":"2229_CR13","doi-asserted-by":"publisher","unstructured":"Wen -S-S, Wu. -Y-J W-J-Y, Ni. -Z-X D-S, Xie. -X-J et al. BRAF V600E \/p-ERK\/p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer. Thyroid\u00ae. 2024;34(2024)(10):1246-59. doi: https:\/\/doi.org\/10.1089\/thy.2023.0700","DOI":"10.1089\/thy.2023.0700"},{"issue":"1","key":"2229_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12943-025-02263-4","volume":"24","author":"Y Wan","year":"2025","unstructured":"Wan Y, Li G, Cui G, Duan S, Chang S. Reprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy. Mol Cancer. 2025;24(1):74. https:\/\/doi.org\/10.1186\/s12943-025-02263-4.","journal-title":"Mol Cancer"},{"issue":"1","key":"2229_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12943-025-02470-z","volume":"24","author":"S Li","year":"2025","unstructured":"Li S, Han H, Yang K, Li X, Ma L, Yang Z, et al. Exosome-mediated metabolic reprogramming: effects on thyroid cancer progression and tumor microenvironment remodeling. Mol Cancer. 2025;24(1):247. https:\/\/doi.org\/10.1186\/s12943-025-02470-z.","journal-title":"Mol Cancer"},{"issue":"5","key":"2229_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/ERC-17-0532","volume":"25","author":"KJ Na","year":"2018","unstructured":"Na KJ, Choi H. Immune landscape of papillary thyroid cancer and immunotherapeutic implications. Endocr Relat Cancer. 2018;25(5):523\u201331. https:\/\/doi.org\/10.1530\/ERC-17-0532.","journal-title":"Endocr Relat Cancer"},{"key":"2229_CR17","doi-asserted-by":"publisher","unstructured":"He Y, Tang Z, Xu M, Huang T. Dedifferentiation and Redifferentiation of Follicular-Cell-Derived Thyroid Carcinoma: Mechanisms and Therapeutic Implications. Biomedicines. 2025;13(12). https:\/\/doi.org\/10.3390\/biomedicines13122982.","DOI":"10.3390\/biomedicines13122982"},{"issue":"2","key":"2229_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12020-007-0027-6","volume":"31","author":"D Rengaraj","year":"2007","unstructured":"Rengaraj D, Gao F, Liang XH, Yang ZM. Expression and regulation of type II integral membrane protein family members in mouse male reproductive tissues. Endocrine. 2007;31(2):193\u2013201. https:\/\/doi.org\/10.1007\/s12020-007-0027-6.","journal-title":"Endocrine"},{"issue":"5","key":"2229_CR19","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1080\/15548627.2015.1034412","volume":"11","author":"S Namkoong","year":"2015","unstructured":"Namkoong S, Lee KI, Lee JI, Park R, Lee EJ, Jang IS, et al. The integral membrane protein ITM2A, a transcriptional target of PKA-CREB, regulates autophagic flux via interaction with the vacuolar ATPase. Autophagy. 2015;11(5):756\u201368. https:\/\/doi.org\/10.1080\/15548627.2015.1034412.","journal-title":"Autophagy"},{"issue":"6","key":"2229_CR20","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.biolcel.2004.04.007","volume":"96","author":"D Van den Plas","year":"2004","unstructured":"Van den Plas D, Merregaert J. In vitro studies on Itm2a reveal its involvement in early stages of the chondrogenic differentiation pathway. Biol Cell. 2004;96(6):463\u201370. https:\/\/doi.org\/10.1016\/j.biolcel.2004.04.007.","journal-title":"Biol Cell"},{"issue":"4","key":"2229_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/21623945.2017.1362510","volume":"6","author":"SJ Davies","year":"2017","unstructured":"Davies SJ, Ryan J, O\u2019Connor PBF, Kenny E, Morris D, Baranov PV, et al. Itm2a silencing rescues lamin A mediated inhibition of 3T3-L1 adipocyte differentiation. Adipocyte. 2017;6(4):259\u201376. https:\/\/doi.org\/10.1080\/21623945.2017.1362510.","journal-title":"Adipocyte"},{"issue":"9","key":"2229_CR22","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.7150\/jca.114801","volume":"16","author":"C Jiang","year":"2025","unstructured":"Jiang C, Feng R, Zhao Y, Zhang J, Han N, Zhang Y, et al. ITM2A as a potential prognostic marker for triple-negative breast cancer. J Cancer. 2025;16(9):2903\u201316. https:\/\/doi.org\/10.7150\/jca.114801.","journal-title":"J Cancer"},{"issue":"5","key":"2229_CR23","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.62347\/KHCC9690","volume":"14","author":"J Jiang","year":"2024","unstructured":"Jiang J, Xu J, Ou L, Yin C, Wang Y, Shi B. ITM2A inhibits the progression of bladder cancer by downregulating the phosphorylation of STAT3. Am J Cancer Res. 2024;14(5):2202\u201315. https:\/\/doi.org\/10.62347\/KHCC9690.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"2229_CR24","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.1080\/21655979.2021.2001218","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Wang J, Gao C, Hu Q, Mao X. Integral membrane protein 2A enhances sensitivity to chemotherapy via notch signaling pathway in cervical cancer. Bioengineered. 2021;12(2):10183\u201393. https:\/\/doi.org\/10.1080\/21655979.2021.2001218.","journal-title":"Bioengineered"},{"key":"2229_CR25","doi-asserted-by":"publisher","first-page":"1501486","DOI":"10.3389\/fimmu.2024.1501486","volume":"15","author":"X Zeng","year":"2024","unstructured":"Zeng X, Yang D, Zhang J, Li K, Wang X, Ma F, et al. Integrating machine learning, bioinformatics and experimental verification to identify a novel prognostic marker associated with tumor immune microenvironment in head and neck squamous carcinoma. Front Immunol. 2024;15:1501486. https:\/\/doi.org\/10.3389\/fimmu.2024.1501486.","journal-title":"Front Immunol"},{"key":"2229_CR26","doi-asserted-by":"publisher","first-page":"1727032","DOI":"10.3389\/fphar.2025.1727032","volume":"16","author":"Y Wan","year":"2025","unstructured":"Wan Y, Xie D, Zhang M, Yang S, Zhang Z, Fu X, et al. Integrating traditional omics and AI-driven approaches for discovery and validation of novel MicroRNA biomarkers and therapeutic targets in thyroid cancer. Front Pharmacol. 2025;16:1727032. https:\/\/doi.org\/10.3389\/fphar.2025.1727032.","journal-title":"Front Pharmacol"},{"key":"2229_CR27","doi-asserted-by":"publisher","unstructured":"Xing W, Feng H, Jiang B, Gao B, Liu J, Xie Z, et al. Itm2a expression marks periosteal skeletal stem cells that contribute to bone fracture healing. J Clin Invest. 2024;134(17). https:\/\/doi.org\/10.1172\/JCI176528.","DOI":"10.1172\/JCI176528"},{"issue":"7","key":"2229_CR28","doi-asserted-by":"publisher","first-page":"e103928","DOI":"10.1371\/journal.pone.0103928","volume":"9","author":"M Kihara","year":"2014","unstructured":"Kihara M, Kiyoshima T, Nagata K, Wada H, Fujiwara H, Hasegawa K, et al. Itm2a expression in the developing mouse first lower molar, and the subcellular localization of Itm2a in mouse dental epithelial cells. PLoS ONE. 2014;9(7):e103928. https:\/\/doi.org\/10.1371\/journal.pone.0103928.","journal-title":"PLoS ONE"},{"issue":"3","key":"2229_CR29","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3892\/ijo.2016.3617","volume":"49","author":"C Dupain","year":"2016","unstructured":"Dupain C, Ali HM, Mouhoub TA, Urbinati G, Massaad-Massade L. Induction of TTF-1 or PAX-8 expression on proliferation and tumorigenicity in thyroid carcinomas. Int J Oncol. 2016;49(3):1248\u201358. https:\/\/doi.org\/10.3892\/ijo.2016.3617.","journal-title":"Int J Oncol"},{"issue":"6","key":"2229_CR30","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1089\/thy.2020.0297","volume":"31","author":"J Ramirez-Moya","year":"2021","unstructured":"Ramirez-Moya J, Santisteban P. A Positive Feedback Loop Between DICER1 and Differentiation Transcription Factors Is Important for Thyroid Tumorigenesis. Thyroid. 2021;31(6):912\u201321. https:\/\/doi.org\/10.1089\/thy.2020.0297.","journal-title":"Thyroid"},{"issue":"8","key":"2229_CR31","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.nucmedbio.2012.07.004","volume":"39","author":"F Feng","year":"2012","unstructured":"Feng F, Wang H, Hou S, Fu H. Re-induction of cell differentiation and (131)I uptake in dedifferentiated FTC-133 cell line by TSHR gene transfection. Nucl Med Biol. 2012;39(8):1261\u20135. https:\/\/doi.org\/10.1016\/j.nucmedbio.2012.07.004.","journal-title":"Nucl Med Biol"},{"key":"2229_CR32","doi-asserted-by":"publisher","first-page":"718578","DOI":"10.3389\/fonc.2021.718578","volume":"11","author":"F Feng","year":"2021","unstructured":"Feng F, Han H, Wu S, Wang H. Crosstalk Between Abnormal TSHR Signaling Activation and PTEN\/PI3K in the Dedifferentiation of Thyroid Cancer Cells. Front Oncol. 2021;11:718578. https:\/\/doi.org\/10.3389\/fonc.2021.718578.","journal-title":"Front Oncol"},{"issue":"4","key":"2229_CR33","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/thy.2022.0533","volume":"33","author":"AV Nikitski","year":"2023","unstructured":"Nikitski AV, Condello V, Divakaran SS, Nikiforov YE. Inhibition of ALK-Signaling Overcomes STRN-ALK-Induced Downregulation of the Sodium Iodine Symporter and Restores Radioiodine Uptake in Thyroid Cells. Thyroid. 2023;33(4):464\u201373. https:\/\/doi.org\/10.1089\/thy.2022.0533.","journal-title":"Thyroid"},{"issue":"3","key":"2229_CR34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci. 2016;41(3):211\u20138. https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001.","journal-title":"Trends Biochem Sci"},{"issue":"9","key":"2229_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/ERC-20-0135","volume":"27","author":"M Wagner","year":"2020","unstructured":"Wagner M, Wuest M, Lopez-Campistrous A, Glubrecht D, Dufour J, Jans HS, et al. Tyrosine kinase inhibitor therapy and metabolic remodelling in papillary thyroid cancer. Endocr Relat Cancer. 2020;27(9):495\u2013507. https:\/\/doi.org\/10.1530\/ERC-20-0135.","journal-title":"Endocr Relat Cancer"},{"key":"2229_CR36","doi-asserted-by":"publisher","unstructured":"Hao Y, Baker D, Ten Dijke P. TGF-beta-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis. Int J Mol Sci. 2019;20(11). https:\/\/doi.org\/10.3390\/ijms20112767.","DOI":"10.3390\/ijms20112767"},{"issue":"1","key":"2229_CR37","doi-asserted-by":"publisher","first-page":"113195","DOI":"10.1016\/j.yexcr.2022.113195","volume":"417","author":"BC Jena","year":"2022","unstructured":"Jena BC, Das CK, Banerjee I, Bharadwaj D, Majumder R, Das S, et al. TGF-beta1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation. Exp Cell Res. 2022;417(1):113195. https:\/\/doi.org\/10.1016\/j.yexcr.2022.113195.","journal-title":"Exp Cell Res"},{"issue":"14","key":"2229_CR38","doi-asserted-by":"publisher","first-page":"12867","DOI":"10.1007\/s00432-023-05164-5","volume":"149","author":"C Shen","year":"2023","unstructured":"Shen C, Liu J, Jiao W, Zhang X, Zhao X, Yang X, et al. A feed-forward loop based on aerobic glycolysis and TGF-beta between tumor-associated macrophages and bladder cancer cells promoted malignant progression and immune escape. J Cancer Res Clin Oncol. 2023;149(14):12867\u201380. https:\/\/doi.org\/10.1007\/s00432-023-05164-5.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2229_CR39","doi-asserted-by":"crossref","unstructured":"Zhang T, Han H, Zhang T, Zhang Y, Ma L, Yang Z et al. Oncogenic mutation-driven metabolism-immunity regulatory axis: Potential prospects for thyroid cancer precision therapy. Biochim et Biophys acta Reviews cancer. 2025;1880(6):189459.","DOI":"10.1016\/j.bbcan.2025.189459"},{"key":"2229_CR40","doi-asserted-by":"publisher","unstructured":"Qiu Y, Su Y, Xie E, Cheng H, Du J, Xu Y et al. Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity. Cancer Cell. 2025;43(1):103\u2009\u2013\u200921 e8. https:\/\/doi.org\/10.1016\/j.ccell.2024.11.003","DOI":"10.1016\/j.ccell.2024.11.003"},{"issue":"1","key":"2229_CR41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2022.12.008","volume":"56","author":"J Park","year":"2023","unstructured":"Park J, Hsueh PC, Li Z, Ho PC. Microenvironment-driven metabolic adaptations guiding CD8(+) T cell anti-tumor immunity. Immunity. 2023;56(1):32\u201342. https:\/\/doi.org\/10.1016\/j.immuni.2022.12.008.","journal-title":"Immunity"},{"issue":"11","key":"2229_CR42","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.20892\/j.issn.2095-3941.2022.0381","volume":"19","author":"J Wissfeld","year":"2022","unstructured":"Wissfeld J, Werner A, Yan X, Ten Bosch N, Cui G. Metabolic regulation of immune responses to cancer. Cancer Biol Med. 2022;19(11):1528\u201342. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2022.0381.","journal-title":"Cancer Biol Med"},{"key":"2229_CR43","doi-asserted-by":"publisher","first-page":"1297932","DOI":"10.3389\/fimmu.2023.1297932","volume":"14","author":"JB Iorgulescu","year":"2023","unstructured":"Iorgulescu JB, Ruthen N, Ahn R, Panagioti E, Gokhale PC, Neagu M, et al. Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model. Front Immunol. 2023;14:1297932. https:\/\/doi.org\/10.3389\/fimmu.2023.1297932.","journal-title":"Front Immunol"},{"issue":"1","key":"2229_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12943-023-01924-6","volume":"23","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liu Y, Sun Y, Liu Q, Gu Y, Huang Y, et al. Aberrant R-loop-mediated immune evasion, cellular communication, and metabolic reprogramming affect cancer progression: a single-cell analysis. Mol Cancer. 2024;23(1):11. https:\/\/doi.org\/10.1186\/s12943-023-01924-6.","journal-title":"Mol Cancer"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02229-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02229-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02229-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:00:26Z","timestamp":1787803226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02229-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2229"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02229-w","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In accordance with the Declaration of Helsinki. The Ethics Committee of Second Affiliated Hospital, Zhejiang University School of Medicine deemed that this research is based on open-source data, so the need for ethics approval was waived.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"307"}}